JONES FINANCIAL COMPANIES LLLP
Position in BTAI — BioXcel Therapeutics, Inc.
CIK 815917
DES PERES, MO
Position in BTAI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$176,597
-$43,707 QoQ
Shares Held
131,789
-4.3% QoQ
Ownership
0.427%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 40 holders
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BTAI Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026JONES FINANCIAL COMPANIES LLLP holds $151,859,373 across 48 Drug Manufacturers - Specialty & Generic names. BTAI ranks #17 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
9,086,528 | $90,956,145 | |
| 2 | ZTS |
Zoetis Inc.
|
179,646 | $21,235,953 | |
| 3 | PBH |
Prestige Consumer Healthcare Inc.
|
250,151 | $14,826,449 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
321,219 | $9,675,116 | |
| 5 | ESPR |
Esperion Therapeutics, Inc.
|
2,135,741 | $5,851,930 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
23,151 | $3,049,911 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
2,960 | $1,755,220 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
54,322 | $675,222 |
All Filings in BTAI
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $176,597 | 131,789 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $220,304 | 137,690 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $92,160 | 36,000 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $47,060 | 26,000 | Shares | Sole | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||